115 related articles for article (PubMed ID: 24967740)
1. Expression of somatostatin receptor subtype 2 and subtype 5 in thyroid malignancies.
Woelfl S; Bogner S; Huber H; Salaheddin-Nassr S; Hatzl M; Decristoforo C; Virgolini I; Gabriel M
Nuklearmedizin; 2014; 53(5):179-85. PubMed ID: 24967740
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma.
Kendler DB; Araújo ML; Alencar R; de Souza Accioly MT; Bulzico DA; de Noronha Pessoa CC; Accioly FA; de Farias TP; Lopes FPPL; Corbo R; Vaisman M; Vaisman F
Endocrine; 2017 Dec; 58(3):474-480. PubMed ID: 28948577
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism.
Traub-Weidinger T; Putzer D; von Guggenberg E; Dobrozemsky G; Nilica B; Kendler D; Bale R; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1995-2001. PubMed ID: 26173620
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical investigation of the expression of somatostatin receptor subtypes - should therapeutic trials be performed to determine the efficacy of somatostatin analogs in treating advanced thyroid malignances?
Pisarek H; Pawlikowski M; Marchlewska M; Minias R; Winczyk K
Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):342-6. PubMed ID: 25962406
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines.
Ain KB; Taylor KD; Tofiq S; Venkataraman G
J Clin Endocrinol Metab; 1997 Jun; 82(6):1857-62. PubMed ID: 9177396
[TBL] [Abstract][Full Text] [Related]
6. Evidence for Somatostatin receptor 2 in thyroid tissue.
Druckenthaner M; Schwarzer C; Ensinger C; Gabriel M; Prommegger R; Riccabona G; Decristoforo C
Regul Pept; 2007 Jan; 138(1):32-9. PubMed ID: 16996150
[TBL] [Abstract][Full Text] [Related]
7. Small Cell Carcinomas of the Bladder Highly Express Somatostatin Receptor Type 2A: Impact on Prognosis and Treatment--A Multicenter Study of Urooncology Society, Turkey.
Neşe N; Kumbaraci BS; Baydar DE; Kiliçaslan I; Sari AA; Şen S; Gönül II; Kankaya D; Özlük Y; Ermete M; Özağari A; Bal N; Kiremitçi S; Yildiz K; Tuna B; Şen N; Yörükoğlu K
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):253-60. PubMed ID: 25906124
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma.
Mato E; Matías-Guiu X; Chico A; Webb SM; Cabezas R; Berná L; De Leiva A
J Clin Endocrinol Metab; 1998 Jul; 83(7):2417-20. PubMed ID: 9661621
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor expression in non-medullary thyroid carcinomas.
Pazaitou-Panayiotou K; Tiensuu Janson E; Koletsa T; Kotoula V; Stridsberg M; Karkavelas G; Karayannopoulou G
Hormones (Athens); 2012; 11(3):290-6. PubMed ID: 22908061
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid.
Papotti M; Kumar U; Volante M; Pecchioni C; Patel YC
Clin Endocrinol (Oxf); 2001 May; 54(5):641-9. PubMed ID: 11380495
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor profiling in hepatic metastases from small intestinal and pancreatic neuroendocrine neoplasms: immunohistochemical approach with potential clinical utility.
Nasir A; Stridsberg M; Strosberg J; Su PH; Livingston S; Malik HA; Kelley ST; Centeno BA; Coppola D; Malafa ME; Yeatman TJ; Kvols LK
Cancer Control; 2006 Jan; 13(1):52-60. PubMed ID: 16508627
[TBL] [Abstract][Full Text] [Related]
12. Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapies.
Srirajaskanthan R; Watkins J; Marelli L; Khan K; Caplin ME
Neuroendocrinology; 2009; 89(3):308-14. PubMed ID: 19307732
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapy.
Lapa C; Werner RA; Schmid JS; Papp L; Zsótér N; Biko J; Reiners C; Herrmann K; Buck AK; Bundschuh RA
Nucl Med Biol; 2015 Apr; 42(4):349-54. PubMed ID: 25595135
[TBL] [Abstract][Full Text] [Related]
14. Expression of somatostatin receptor subtypes in human pituitary adenomas -- immunohistochemical studies.
Pisarek H; Pawlikowski M; Kunert-Radek J; Radek M
Endokrynol Pol; 2009; 60(4):240-51. PubMed ID: 19753537
[TBL] [Abstract][Full Text] [Related]
15. Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis.
Herac M; Niederle B; Raderer M; Krebs M; Kaserer K; Koperek O
APMIS; 2016 Oct; 124(10):839-45. PubMed ID: 27539746
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor expression in thyroid disease.
Atkinson H; England JA; Rafferty A; Jesudason V; Bedford K; Karsai L; Atkin SL
Int J Exp Pathol; 2013 Jun; 94(3):226-9. PubMed ID: 23672766
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor subtype expression in human thyroid tumours.
Klagge A; Krause K; Schierle K; Steinert F; Dralle H; Fuhrer D
Horm Metab Res; 2010 Apr; 42(4):237-40. PubMed ID: 20094970
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.
Rostomily RC; Elias M; Deng M; Elias P; Born DE; Muballe D; Silbergeld DL; Futran N; Weymuller EA; Mankoff DA; Eary J
Head Neck; 2006 Apr; 28(4):305-12. PubMed ID: 16470879
[TBL] [Abstract][Full Text] [Related]
19. [Examination of somatostatin receptor expression in recurrent childhood medulloblastomas].
Kaszper E; Hanzély Z; Szende B; Dabasi G; Garami M; Schuler D; Hauser P
Magy Onkol; 2008 Dec; 52(4):351-5. PubMed ID: 19068462
[TBL] [Abstract][Full Text] [Related]
20. 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.
Forssell-Aronsson EB; Nilsson O; Bejegård SA; Kölby L; Bernhardt P; Mölne J; Hashemi SH; Wängberg B; Tisell LE; Ahlman H
J Nucl Med; 2000 Apr; 41(4):636-42. PubMed ID: 10768564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
